Clinical Trial Update: Survivorship Promotion In Reducing IGF-1 Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating survivorship promotion by reducing IGF-1 has completed, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Endometrial Cancer
• Hepatocellular Carcinoma
• Lung Cancer
• Melanoma
• Pancreatic Cancer
• Prostate Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Breast Cancer, Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-09-16